Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ovation and DSG collaborate in several Phase I studies
To date, Ovation has used eCaseLink for five Phase I studies, and has seven Phase I studies underway or planned for 2008 and six Phase I studies planned
To date, Ovation has used eCaseLink for five Phase I studies, and has seven Phase I studies underway or planned for 2008 and six Phase I studies planned
Most recently chief technology officer for Vyteris, Mr Hartounian previously served as a director and CEO of Protagenic Therapeutics, a biotechnology company he founded in 2006 to treat
Under the agreement, AngioDynamics has acquired Oncobionic for a total purchase price of $25.4 million, including approximately $400,000 of assumed liabilities. A deposit of $5 million was paid
Under the terms of the collaboration, Kai will receive an upfront cash payment of $25 million. Bristol-Myers Squibb will fund all future development, including the Phase IIb clinical
The company recently registered in the State of Florida to do business as ONI BioPharma. The company will refer to itself as Oni BioPharma from this point forward
This agreement with Embil, a multi-national dermatology company based in Turkey, is the company’s second entry into the $2.8 billion acne market. The territory includes Turkey, Azerbaijan, Kazakhstan,
The newly released data indicate that the Endeavor stent offers durable efficacy out to four years of follow-up, with no new events requiring target lesion revascularization (TLR) between
The IsoFlex Optim lead can be used with pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. The small-diameter lead is built on the proven IsoFlex
Recent advances in DNA-sequencing technology have increased the speed of data acquisition. However, without accompanying improvements in the ability to select relevant portions of the genome, the technology
The names of the companies and the terms of these agreements have not been disclosed for proprietary reasons. Working with its regional marketing representative, Bioxel is actively securing